Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Physical Chemistry Chemical Physics : PCCP|August 29, 2025
Computational design of an improved photoswitchable psychedelic based on light absorption, membrane permeation and protein bindingVito F Palmisano, Claudio Agnorelli, Shirin Faraji, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 19, 2026
Recent advances in PET measures of brain 5-HT releaseClaudio Agnorelli, Hanne Demant Garling, Louise M Paterson, et al.
Biochemistry|February 7, 2024
Membrane Permeation of Psychedelic Tryptamines by Dynamic SimulationsVito F Palmisano, Claudio Agnorelli, Andrea Fagiolini, et al.
EJNMMI Physics|March 10, 2026
Evaluation of the impact of low activity imaging in [11C]-(+)-PHNO and [11C]UCB-J PET-MR scansDaniela Ribeiro, William Hallett, Oliver Howes, et al.
Sleep|July 10, 2021
Granule cells in the infrapyramidal blade of the dentate gyrus are activated during paradoxical (REM) sleep hypersomnia but not during wakefulness: a study using TRAP miceRisa Yamazaki, Dianru Wang, Anna De Laet, et al.
Frontiers in Psychiatry|June 28, 2023
Psychedelic therapy in the treatment of addiction: the past, present and futureRayyan Zafar, Maxim Siegel, Rebecca Harding, et al.
Neuroscience and Biobehavioral Reviews|April 4, 2025
Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical modelsClaudio Agnorelli, Meg Spriggs, Kate Godfrey, et al.
Biochemical Pharmacology|March 13, 2021
Is REM sleep a paradoxical state?: Different neurons are activated in the cingulate cortices and the claustrum during wakefulness and paradoxical sleep hypersomniaRenato Maciel, Risa Yamazaki, Dianru Wang, et al.
Molecular Psychiatry|January 14, 2025
Neurophysiological correlates of ketamine-induced dissociative state in bipolar disorder: insights from real-world clinical settingsClaudio Agnorelli, Alessandra Cinti, Giovanni Barillà, et al.
Frontiers in Psychiatry|January 26, 2024
Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trialEllen James, David Erritzoe, Tiffanie Benway, et al.
Pageof 2